Manuela Gencarelli

Florence, 50139, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Fibroblast growth factor 21 prevents catecholaminergic arrhythmias in a mouse model of PKP2 arrhythmogenic cardiomyopathy.

Fibroblast growth factor 21 prevents catecholaminergic arrhythmias in a mouse model of PKP2 arrhythmogenic cardiomyopathy.

Journal: Heart rhythm
Published: November 19, 2025

Adeno-associated virus-mediated PKP2 gene therapy confers robust exercise tolerance in a murine model of arrhythmogenic cardiomyopathy.

Adeno-associated virus-mediated PKP2 gene therapy confers robust exercise tolerance in a murine model of arrhythmogenic cardiomyopathy.

Journal: Heart rhythm
Published: April 23, 2025

Interleukin-6 Modulates the Expression and Function of HCN Channels: A Link Between Inflammation and Atrial Electrogenesis.

Interleukin-6 Modulates the Expression and Function of HCN Channels: A Link Between Inflammation and Atrial Electrogenesis.

Journal: International journal of molecular sciences
Published: October 15, 2024

Single Construct Suppression and Replacement Gene Therapy for the Treatment of All CALM1-, CALM2-, and CALM3-Mediated Arrhythmia Disorders.

Single Construct Suppression and Replacement Gene Therapy for the Treatment of All CALM1-, CALM2-, and CALM3-Mediated Arrhythmia Disorders.

Journal: Circulation. Arrhythmia and electrophysiology
Published: July 29, 2024

Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling.

Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling.

Journal: Marine drugs
Published: April 15, 2023

Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1).

Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1).

Journal: International journal of molecular sciences
Published: January 04, 2022

The 3-iodothyronamine (T1AM) and the 3-iodothyroacetic acid (TA1) indicate a novel connection with the histamine system for neuroprotection.

The 3-iodothyronamine (T1AM) and the 3-iodothyroacetic acid (TA1) indicate a novel connection with the histamine system for neuroprotection.

Journal: European journal of pharmacology
Published: June 24, 2021

Commentary: Euthyroid Sick Syndrome in Patients With COVID-19.

Commentary: Euthyroid Sick Syndrome in Patients With COVID-19.

Journal: Frontiers in endocrinology
Published: November 24, 2020

3-Iodothyronamine Affects Thermogenic Substrates' Mobilization in Brown Adipocytes.

3-Iodothyronamine Affects Thermogenic Substrates' Mobilization in Brown Adipocytes.

Journal: Biology
Published: April 02, 2020

Angiotensin-II Drives Human Satellite Cells Toward Hypertrophy and Myofibroblast Trans-Differentiation by Two Independent Pathways.

Angiotensin-II Drives Human Satellite Cells Toward Hypertrophy and Myofibroblast Trans-Differentiation by Two Independent Pathways.

Journal: International journal of molecular sciences
Published: August 01, 2019

N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity.

N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity.

Journal: Neurochemistry international
Published: March 18, 2019

Brain Histamine Modulates the Antidepressant-Like Effect of the 3-Iodothyroacetic Acid (TA1).

Brain Histamine Modulates the Antidepressant-Like Effect of the 3-Iodothyroacetic Acid (TA1).

Journal: Frontiers in cellular neuroscience
Published: February 19, 2019
Showing 1-12 of 13

Last Updated: 09/26/2026